Sarepta Therapeutics, Inc. technical analysis
Technical analysis of Sarepta Therapeutics, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Sarepta Therapeutics, Inc.
Sarepta Therapeutics is a biopharmaceutical company that develops RNA-targeted therapies, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. The company commercializes drugs for Duchenne muscular dystrophy (EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS) and develops additional therapeutic programs in clinical trials. It was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Description generated automatically from public sources; it may be inaccurate or out of date.
Sarepta Therapeutics, Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
19.57 $
+14.95%
50 sessions
18.21 $
+23.56%
200 sessions
19.18 $
+17.30%
Session levels
s2
22.00
Support
s1
22.49
Support
pivot
22.92
Pivot
r1
23.41
Resistance
r2
23.84
Resistance
How to read it
In the September 4, 2026 session Sarepta Therapeutics, Inc. closed lower at 22.50 $, −2.13% versus the previous session.
The price sits above every moving average observed: +14.95% against the 21-session average, +23.56% against the 50 and +17.30% against the 200.
The 14-period RSI reads 68.0, in neutral territory.
MACD stands at 1.387 against a signal line at 1.016: the histogram is positive (+0.371).
ADX reads 34.4, indicating a marked directionality.
Levels computed on the latest session place supports at 22.49 and 22.00 $ and resistances at 23.41 and 23.84 $, around a pivot of 22.92.
The average daily range (ATR) is 1.230 $, or 5.47% of price.
Turnover was 3M shares, 106% of the 20-session average.
Over the last twelve months the price ranged between 14.68 and 23.85 $, and today stands −5.66% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the SRPT analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Sarepta Therapeutics, Inc.
How is Sarepta Therapeutics, Inc. analysed technically?
Technical analysis of Sarepta Therapeutics, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Sarepta Therapeutics, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Sarepta Therapeutics, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Sarepta Therapeutics, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.